Despre babesioza canină
The objective of this bibliographic essay, addressed both to veterinary clinicians and researchers, is to bring to mind the disease in terms of etiology, clinical manifestations and therapeutic and prophylactic management, as well as to remind the issues arising from recent researches. Depending on...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar
2016-06-01
|
| Series: | Medicamentul Veterinar |
| Online Access: | http://www.veterinarypharmacon.com/docs/1653-2016_VD_10(1)_Art.3.Ro.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839602791774945280 |
|---|---|
| author | Andrei Nanu |
| author_facet | Andrei Nanu |
| author_sort | Andrei Nanu |
| collection | DOAJ |
| description | The objective of this bibliographic essay, addressed both to veterinary clinicians and researchers, is to bring to mind the disease in terms of etiology, clinical manifestations and therapeutic and prophylactic management, as well as to remind the issues arising from recent researches. Depending on the virulence of the parasite species, body's immune response and therapeutic management approached, the plateau of disease evolution can be quite wide - from a favorable prognosis to a lethal outcome of the animal. The complexity of the pathogenic mechanism in babesiosis is due to soluble parasite antigens (SPA) which, according to recent studies, have been obtained in vitro and then used as immunological product in disease prevention. Producing a vaccine against canine babesiosis with parasite antigens of local strains could play an important role to prevent the clinical expression of this disease in Romania. |
| format | Article |
| id | doaj-art-4b6b19b32ac24bfe81f07008d08b2c0c |
| institution | Matheson Library |
| issn | 1843-9527 2069-2463 |
| language | English |
| publishDate | 2016-06-01 |
| publisher | Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar |
| record_format | Article |
| series | Medicamentul Veterinar |
| spelling | doaj-art-4b6b19b32ac24bfe81f07008d08b2c0c2025-08-02T07:16:32ZengAsociaţia Naţională a Fabricanţilor de Produse de Uz VeterinarMedicamentul Veterinar1843-95272069-24632016-06-011014247Despre babesioza caninăAndrei Nanu 0Romvac Company S.A. The objective of this bibliographic essay, addressed both to veterinary clinicians and researchers, is to bring to mind the disease in terms of etiology, clinical manifestations and therapeutic and prophylactic management, as well as to remind the issues arising from recent researches. Depending on the virulence of the parasite species, body's immune response and therapeutic management approached, the plateau of disease evolution can be quite wide - from a favorable prognosis to a lethal outcome of the animal. The complexity of the pathogenic mechanism in babesiosis is due to soluble parasite antigens (SPA) which, according to recent studies, have been obtained in vitro and then used as immunological product in disease prevention. Producing a vaccine against canine babesiosis with parasite antigens of local strains could play an important role to prevent the clinical expression of this disease in Romania.http://www.veterinarypharmacon.com/docs/1653-2016_VD_10(1)_Art.3.Ro.pdf |
| spellingShingle | Andrei Nanu Despre babesioza canină Medicamentul Veterinar |
| title | Despre babesioza canină |
| title_full | Despre babesioza canină |
| title_fullStr | Despre babesioza canină |
| title_full_unstemmed | Despre babesioza canină |
| title_short | Despre babesioza canină |
| title_sort | despre babesioza canina |
| url | http://www.veterinarypharmacon.com/docs/1653-2016_VD_10(1)_Art.3.Ro.pdf |
| work_keys_str_mv | AT andreinanu desprebabesiozacanina |